Peer-reviewedCC BYPharmaceuticals (Basel, Switzerland)
Targeting Neuroinflammation After Traumatic Brain Injury: Addressing Sex Differences to Improve Clinical Translation
Related
- Dendrimer Delivered shRNA Targeting the CCL20-CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain Injury
- Targeting the RNA regulator HuR in acute traumatic brain injury mitigates secondary injury and improves functional outcome by suppressing neuroinflammation
- Sympathetic Modulation of Neuroinflammation by Reserpine Improves Neurogenesis in ICR Mice with Traumatic Brain Injury
- Kaempferol attenuates secondary brain injury after traumatic brain injury in mice with reduced neuroinflammation
- In situ delivery of cannabidiol-loaded GelMA sponge attenuates cerebral edema and neuroinflammation in traumatic brain injury
BibTeX
@article{anon2026targeting,
title = {{Targeting Neuroinflammation After Traumatic Brain Injury: Addressing Sex Differences to Improve Clinical Translation}},
journal = {Pharmaceuticals (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13708345},
note = {CC BY},
}
RIS
TY - JOUR
TI - Targeting Neuroinflammation After Traumatic Brain Injury: Addressing Sex Differences to Improve Clinical Translation
PY - 2026
DA - 2026/10/01
JO - Pharmaceuticals (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13708345
SN - 1424-8247
ER -